The Locus Control Region (LCR) of the human globin gene domain is defined by four erythroid-specific DNasel hypersensitive sites (HSS) located upstream of this multigene cluster. The LCR confers copy number dependent high levels of erythroid specific expression to a linked transgene, independent of the site of integration. To assess the role of the individual hypersensitive sites of the LCR, we have localized HSS4 to a 280bp fragment that is functional both in murine erythroleukaemia (MEL) cells and in transgenic mice. This fragment coincides with the major area of hypersensitivity 'in vivo' and contains a number of DNasel footprints. Bandshift analysis shows that these footprints correspond to binding sites for the erythroid specific proteins GATAI and NF-E2 and a number of ubiquitous proteins, including jun/fos, Spl and TEF2.
INTRODUCTION
The human globin gene locus consists of the embryonic e globin gene, the foetal yGand y genes, and the adult 6 and globin genes arranged in a 5' to 3' directionl ( Fig. 1) . A 5kb fragment containing the human globin gene and flanking regions contains sufficient information to be expressed in a tissue and developmentally specific manner in transgenic mice2'3'4, but expression levels are very low when compared to the endogenous mouse globin genes. Moreover, the transgenes are highly susceptible to position effects. A major breakthrough in overcoming this problem came from the study of a heterozygous Dutch -y( thalassaemia, which has a 10OKb deletion 5' of the otherwise unaltered human globin gene5,6'7. This allele is not expressed in the same cells that express the other (wild type) allele, suggesting that the sequences governing the expression of human globin should be contained within the deletion. Four strong developmentally stable erythroid specific HSS upstream of the e globin gene8'9 10 were good candidates for such a control region. To test this possibility the four HSS were linked to a human globin gene and shown to confer erythroid specific position independent expression on the transgene in mice at levels (per gene copy) comparable to the endogenous mouse globin genes'0. The original construct, termed the minilocus, contained the four HSS in their natural configuration on a 20Kb fragment (Fig. 1) . This was reduced to 6 .5kb without losing the essential properties of the minilocus, by cloning the individual HSS on smaller restriction fragments" (Fig. 1, microlocus) . This has allowed us to study the role of each HSS and to characterize the factors binding to each of the sites.
Stable transformation experiments with individual sites in MEL cells showed that the major activities were associated with HSS 3 and 212, the latter of which also shows activity in transient transfections'3. Analysis in transgenic mice confirmed the properties of HSS 3 and 2, but showed that HSS 4 had a similar activity to HSS 2. HSS 1 showed very low levels of activity in both systems in agreement with the observation that a Spanish 6(3 thalassaemial4"5 which has a deletion of HSS 2, 3 and 4 (retaining HSS 1), shows no (3-globin gene activity.
We have previously studied HSS 2 and 3 in detail and shown that the functional activity of these sites is retained on fragments coinciding with the region that is hypersensitive in red cells '6"7. In this paper we have used a similar approach to map the position of HSS 4 (Fig. ID) . For transfections, plasmids were linearized with PvuI. To generate transgenic mice, the SalI-EcoRV fragment containing the HSS and the human ,B-globin gene was isolated and blunted. Transgenic mice containing HSS 4 as a 2.1kb BamHI-XbaI fragment have been described previously'9.
Tissue culture and DNA transfections The MEL cell line C88 was transfected by electroporation with 20,Ag of linearized plasmid DNA using a Bio-Rad Gene Pulsar set at 250 V, 960 /%F. All other details are as described20.
Transgenic mice
Constructs were dissolved at a concentration of 1 -42g/mi and injected into the male pronucleus of fertilized oocytes. 13.5 day foetuses were dissected and screened by Southern blotting using the second intron of the human (3-globin gene to detect the transgene and the 3' ApaI fragment of the endogenous mouse Thy-I as a loading control. All transgenic foetuses were checked for mosaicism by comparing the signal of the transgene to that of the Thy-I gene in DNA samples from body, yolk sac and placenta from the same foetus. RNA was analyzed by SI nuclease protection as describedll. DNaseI footprinting and band shift assays The 280bp SstI-AvaI fragment was blunted and cloned in both orientations in the SmaI site of M13 mp8. Other details are as described previously'6, except that the band shift gels contained 0.5 xTBE. The oligonucleotides used in this study are indicated in Fig. 4 . Competitors were as described'6 or as shown in Fig. 4 .
RESULTS

Fine mapping of hypersensitive site 4
Nuclei were isolated from the MEL clone 5 and the L-cell population 200, both of which have been stably transfected with the minilocus (Fig. 1) as described previously'8'2' and treated with different amounts of DNaseI. After purification, the DNA was digested with either BamHI or XbaI, Southern blotted and hybridized with the 250bp BamHI-HaelH and the 290bp BstNIXbaI fragments, respectively (Fig. 2) . A clear area of hypersensitivity is found in erythroid cells only, at similar DNaseI concentrations as had been previously noted for HSS 2 and 3. There is no apparent change in HSS 4 after induction of MEL differentiation with DMSO (not shown). The same construct in non-erythroid L-cells does not display this hypersensitivity.
From comparisons with the mobility of Sau3AI double digest bands, we conclude that HSS 4 maps from 650 to 900bp from the 5' BaniHI site 'in vivo' and these co-ordinates will be used henceforth (Fig.4) . It is interesting to note that this area falls almost completely outside the fragment used to construct the socalled MLAR22. That particular yLAR fragment starts at the PstI site at 875 and overlaps only with the 3' end of the hypersensitive area (Fig.4) .
Functional analysis of the hypersensitive site A 280bp SstI-AvaI fragment from 650 to 930bp 3' to the BamHI site that overlaps with the area of hypersensitivity was blunted and cloned into the HpaI site at -800bp in the promoter of the human 3-globin gene'6 ( Fig. 1) . This construct and a vector containing the full microlocus driving the 3-globin genel" or only a (3-globin gene were linearized with PvuI and three independent stably transfected MEL cell populations were generated for each construct by electroporation2*. RNA was isolated from these populations four days after induction with DMSO and quantitated by SI nuclease protection analysis (Fig.  3) . The level of the human (3-globin test gene with the HSS 4 deletion is considerably lower (approx 4%) than when driven by the full microlocus, but it is still much higher than the (3 globin gene without the HSS 4 ( Table 1 ). The 4% level is similar to that obtained with the much longer 2.1kb BamHI-XbaI fragment driving the human (3-globin gene'2.
An important feature of LCR elements is that they render expression of a linked gene independent from its site of integration in transgenic mice, hence expression levels follow the copy number of the transgene. Especially at low transcription levels this characteristic property of the LCR cannot be assayed easily in MEL cells; transfected cells are selected for G418 resistance, such that only integration events into active chromatin regions are observed.
We therefore used the HSS 4 deletion construct to generate transgenic mice. The construct described above was digested with SailI and EcoRV (Fig. 1) , blunted, gel purified and injected into the male pronucleus of fertilized mouse eggs. Foetuses were analyzed 13.5 days after transfer of the eggs and transgenic foetuses were identified by Southern blots of EcoRI digested placenta DNA'0; comparison of the transgene signal to that of the endogenous Thy-I gene allowed an estimation of the transgene copy number. Each foetus was screened for mosaicism by comparing the Thy-1/transgene ratio in DNA from the body, yolk and EcoRV sites were used to isolate the fragment for injection in ferfilized mouse eggs.
sac and placenta from the same animal. Using these criteria, one of the five transgenic offspring was highly mosaic (Table 1) . SI analysis of the transgenic mice is presented in Fig. 3 . We note that the animal with the highest copy number (no. 23) was anaemic, due to chain imbalance caused by overproduction of human 13- Based on the DNaseI footprinting we designed a number of oligonucleotides covering the footprinted areas and used these in bandshift experiments (Fig. 5) . Oligonucleotide 870 is a double GATA-1 binding site, since the shifted products are efficiendly competed by the -200 GATA-1 site of the human 3-globin gene24. This is in agreement with the footprinting data (Fig. 4) a strong hypersensitive site on one side of the helix24-27. Interestingly, the 870 GATA-1 site contains two consensus binding sites in opposite orientation and from the bandshift competitions, we conclude that GATA-1 molecules can bind to both sites simultaneously (Fig. 5, 870 oligo, slower migrating complex). Similar arrays are found in HSS 2 and 3 of the human ,B-globin LCR'6"17 and in the chicken (3-globin 3' enhancer26'27.
Interestingly the latter has recently been shown to direct copy number dependent expression of a linked transgene28. The 810 oligonucleotide contains a consensus for jun/fos/NF-E229 which has previously been shown to be important for the function of the PBGD promoter30 and the (3 globin HSS 217,31. As shown in Fig. 5 , NF-E2 and jun/fos indeed bind to this sequence 'in vitro' and we anticipate that the single site in HSS 4 acts as an enhancing element'7'31.
Two oligonucleotides, 670 and 790, did not show any specific bandshift in vitro (not shown), while oligonucleotides 700, 840, 890 and 920 bind ubiquitous proteins (Fig. 5) . The nature of the proteins binding to the 700 oligonucleotide are as yet unclear because the bandshifts were not competed by oligonucleotides from HSS 2, 3 or the other oligonucleotides of HSS 4. The 840, 890 and 920 oligonucleotides are all capable of binding the general transcription factors Spl32 and the CACC box binding protein TEF-233 (Fig. 5) . In addition, oligonucleotide 840 binds J-BP, a factor also found in HSS 2 and 3, as demonstrated by the competition for binding using the J-BP binding site from the HSS 2 (Fig. 5, panel 840) . These general transcription factors may be required for proper functioning of HSS 4, contributing to its tissue-specific character via synergistic interactions with GATA-1 and NF-E2. Oligonucleotide probes covering the footprinted areas (see Fig. 4 
